Alexey Kotelnikov

Dr. Alexey Kotelnikov

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2019 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Closed access
YPYu. I. Patyutko
Yu. I. Patyutko
AKAlexey Kotelnikov
Alexey Kotelnikov
APA. N. Polyakov
A. N. Polyakov
VPV. D. Podluzhnyi
V. D. Podluzhnyi
Development of surgical approach for pancreatic head and periampullary cancer at the Blokhin National Medical Research Center of Oncology over the past 30 years and global surgical tendencies of surgery for pancreatic cancer are demonstrated in the article. Over this period, gastropancreaticoduodenectomy has evolved from standard procedure without complete lymph node dissection and neurodissection and extended gastropancreaticoduodenectomy with obligatory circular skeletonization of superior mesenteric artery and para-aortic lymphadenectomy to standard gastropancreaticoduodenectomy. The last procedure implies mandatory skeletonization of the right semicircle of superior mesenteric artery, all tubular structures of hepatoduodenal ligament and possible resection of portal and superior mesenteric vein for suspected invasion. Surgical possibilities in the treatment of patients with pancreatic head and periampullary cancer are exhausted. The concept of “early diagnosis” is not applicable for patients with ductal pancreatic cancer. Further progress is exclusively associated with medicamentous combined treatment based on the molecular-biological characteristics of pancreatic and periampular cancer and, possibly, with primary prevention of pancreatic cancer.

12 May 2024 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
FAF. Sh. Akhmetzyanov
F. Sh. Akhmetzyanov
AKAlexey Kotelnikov
Alexey Kotelnikov
MTM. D. Ter-Ovanesov
M. D. Ter-Ovanesov
VEVasiliy Egorov
Vasiliy Egorov
TGT. D. Gostyunin
T. D. Gostyunin
OKO. A. Karpeeva
O. A. Karpeeva
Background. Pancreaticoduodenal resection (PDR) is the surgical procedure for cancer of the head of the pancreas, distal common bile duct, duodenum and ampulla of Vater. This surgery is associated with a high risk of complications, the development of which can be influenced by various factors. since pancreatic fistula is a key complication of PDR, the choice of the method for pancreatic anastomosis becomes especially important. Material and methods. The search for publications was carried out using the PubMed and Elibrary systems from January 1980 to January 2024. of the 2,300 sources found, 69 were used to write the review. We included data from both retrospective and prospective clinical trials that were devoted to pancreatoduodenectomy for malignant neoplasms, the difficulties encountered in performing this surgery and ways to solve them. Results. Currently, there are more than 60 types of pancreatico-digestive anastomosis, which indirectly indicates the absence of a universal one that ensures the prevention of pancreatic fistula. The treatment outcomes may be influenced by the nature of neoadjuvant treatment, concomitant diseases, anatomical features, presence of obstructive jaundice and methods of its relief. The main mechanisms of influence of negative factors on the development of complications are considered. an individual approach to the patient, taking into account all factors, can significantly reduce the risk of complications.

20 September 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPYu. I. Patyutko
Yu. I. Patyutko
DPD. V. Podluzhny
D. V. Podluzhny
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kudashkin
N. E. Kudashkin
ЮПЮ. И. Патютко
Ю. И. Патютко
The paper presents the results of various studies and meta-analyses which focus on assessing the frequency of formation of clinically significant pancreatic fistulas in various types of pancreatic-digestive anastomoses. Pancreatodigestive anastomosis is not an independent predictive factor of pancreatic complications. None of the modern types of pancreatodigestive anastomosis has proved its superiority. The choice of the pancreatodigestive anastomosis method is based on the correct selection of the organ with which the pancreatic stump is connected and the surgeon’s experience and skill in forming the anastomosis.

22 December 2019 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Closed access
PDF file
YPYu. I. Patyutko
Yu. I. Patyutko
AIA. A. Ivanov
A. A. Ivanov
DPD. V. Podluzhny
D. V. Podluzhny
AKAlexey Kotelnikov
Alexey Kotelnikov
APA. N. Polyakov
A. N. Polyakov
ЮПЮ. И. Патютко
Ю. И. Патютко
Повторные резекции печени у больных колоректальным раком с метастазами

19 March 2023 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
AKAlexey Kotelnikov
Alexey Kotelnikov
YPY. I. Patyutko
Y. I. Patyutko
DPD. V. Podluzhnyi
D. V. Podluzhnyi
MSM. S. Saakyan
M. S. Saakyan
NKN. E. Kushlinski
N. E. Kushlinski
ЮПЮ. И. Патютко
Ю. И. Патютко
At present, pancreaticoduodenoctomy causes the high incidence of complications. However, it is associated with an acceptable level of postoperative mortality. With this regard and taking into consideration a significant increase in survival in pancreatic cancer, it is highly relevant to study the negative functional outcomes of surgery and develop methods for their surgical prevention. The bibliographic review focuses on the features of three main postsurgical syndromes: gastric stasis, pancreatic exocrine and endocrine insufficiency. The study shows the dependence of these syndromes on pathomorphological characteristics of pancreatic stump, preservation of the pyloric, the variant of pancreatodigestive anastomosis and other features of reconstructive stage of the surgery.

19 December 2025 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
APA.N. Polyakov
A.N. Polyakov
YPYu.I. Patyutko
Yu.I. Patyutko
AKAlexey Kotelnikov
Alexey Kotelnikov
IBI.S. Bazin
I.S. Bazin
ASA.YU. Syskova
A.YU. Syskova
DPD.V. Podluzhny
D.V. Podluzhny
Objective. To determine prognostic factors in resectable common bile duct (CBD) cancer and feasibility of adjuvant therapy. Material and methods. We retrospectively studied the results of pancreatoduodenectomy for CBD cancer in 1999—2023. Results. There were 89 patients, mortality rate was 5.6% (n=5), complications developed in 66 patients (74.2%), complications ≥ grade III — in 37 (41.7%) cases. Postoperative pancreatic fistula (POPF) grade B/C was detected in 29 (32.6%) cases. Postoperative chemotherapy was administered to 43 patients (gemcitabine-based therapy — 27, capecitabine alone — 15, capecitabine/oxaliplatin combination — 1). The median overall survival was 33 months, disease-free survival — 19 months. Among patients selected for assessment of long-term results (n=79), the median OS was 37 months, DFS — 30 months. Retroperitoneal invasion (RPI), pancreatic invasion (PI), perineural invasion (PNI), moderate/poor differentiation, R1 resection, retroperitoneal lymph node (LN) involvement worsened long-term results in multivariate analysis, regional LN involvement and elevated CA 19-9 — in univariate analysis. Accumulation of factors worsened prognosis. Postoperative chemotherapy improved OS (median OS 35 months vs. 16.5, p=0.035) in patients with two or more negative prognostic factors. Chemotherapy mode did not affect prognosis. Conclusion. Retroperitoneal, pancreatic and perineural invasion, R1 resection, moderate/poor tumor differentiation, lymph node involvement and elevated CA 19-9 are negative prognostic factors in CBD cancer. Postoperative capecitabine monotherapy is justified in patients with two or more negative factors.